Empowering global health innovation in the European Union

Unlocking neglected disease R&D with pull funding mechanisms

Wednesday, 25 September 2024 | 09:00-10:00 | Kursaal

Organised by Deutsche Stiftung Weltbevölkerung

Despite the EU’s leadership in science, a gap persists in translating excellent research into final products. This session examines the EU's role in addressing unmet medical needs for neglected diseases through innovative financing mechanisms. Climate change is introducing diseases like Dengue and malaria to Europe, while rising antimicrobial resistance reduces treatment effectiveness. The erosion of democratic institutions, overstretched healthcare systems, public funding constraints, and post-COVID-19 fatigue highlight the need for EU leadership in global health as a top priority. Introducing pull funding mechanisms such as priority review vouchers will be crucial to transforming research into tangible health and societal benefits and showcase the value of global health investments. The revision of EU pharmaceutical legislation, the new Biotechnology strategy, and the European Health Emergency Preparedness and Response Authority (HERA) offer entry points for these incentives. This discussion will explore ways to strengthen Europe's global health innovation ecosystem to effectively address persistent and emerging health challenges.

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

The European Health Forum Gastein has received funding under a project grant from the European Union’s EU4Health programme 2021-2027. Views and opinions expressed on this website are however those of the author only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria